FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2967364098> ?p ?o ?g. }

• W2967364098 endingPage "1138" @default.
• W2967364098 startingPage "1138" @default.
• W2967364098 abstract "Here, we report a novel antibody drug conjugate (ADC) with the humanized anti-CD26 monoclonal antibody YS110 and triptolide (TR-1). YS110 has an inhibitory activity against the CD26-positive tumor growth via the immunological and direct pathway, such as intra-nuclear transportation of CD26 and YS110, and suppressed transcription of RNA polymerase II (Pol II) subunit POLR2A. The ADC conjugated with YS110 and an antitumor compound triptolide (TR-1), which is an inhibitor for TFIIH, one of the general transcription factors for Pol II was developed. YS110 and triptolide were crosslinked by the heterobifunctional linker succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) and designated Y-TR1. Antitumor efficacy of Y-TR1 against malignant mesothelioma and leukemia cell lines were assessed by the in vitro cell viability assay and in vivo assay using xenografted mouse models. Y-TR1 showed significant cytotoxicity against CD26-positive cell lines but not CD26-negative counterparts in a dose-dependent manner via suppression of mRNA synthesis by impairment of the Pol II activity. The tumors in xenografted mice administered Y-TR1 was smaller than that of the unconjugated YS110 treated mice without severe toxicity. In conclusion, the novel compound Y-TR1 showed antitumor properties against CD26-positive cancer cell lines both in vitro and in vivo without toxicity. The Y-TR1 is a unique antitumor ADC and functions against Pol II." @default.
• W2967364098 created "2019-08-22" @default.
• W2967364098 creator A5045538077 @default.
• W2967364098 creator A5049975494 @default.
• W2967364098 creator A5053699829 @default.
• W2967364098 creator A5055536684 @default.
• W2967364098 creator A5057197316 @default.
• W2967364098 creator A5086946782 @default.
• W2967364098 creator A5089761965 @default.
• W2967364098 creator A5091811703 @default.
• W2967364098 date "2019-08-08" @default.
• W2967364098 modified "2023-10-14" @default.
• W2967364098 title "Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synthesis" @default.
• W2967364098 cites W1845783963 @default.
• W2967364098 cites W192515921 @default.
• W2967364098 cites W1964824569 @default.
• W2967364098 cites W1966122087 @default.
• W2967364098 cites W1979403925 @default.
• W2967364098 cites W1983623192 @default.
• W2967364098 cites W1989926632 @default.
• W2967364098 cites W2001765718 @default.
• W2967364098 cites W2002574573 @default.
• W2967364098 cites W2009059082 @default.
• W2967364098 cites W2010922747 @default.
• W2967364098 cites W2011162627 @default.
• W2967364098 cites W2023648132 @default.
• W2967364098 cites W2033112544 @default.
• W2967364098 cites W2034546452 @default.
• W2967364098 cites W2057110758 @default.
• W2967364098 cites W2065346431 @default.
• W2967364098 cites W2066048691 @default.
• W2967364098 cites W2073205921 @default.
• W2967364098 cites W2074976827 @default.
• W2967364098 cites W2077414734 @default.
• W2967364098 cites W2083982805 @default.
• W2967364098 cites W2085760714 @default.
• W2967364098 cites W2093536578 @default.
• W2967364098 cites W2100988726 @default.
• W2967364098 cites W2112663540 @default.
• W2967364098 cites W2122269058 @default.
• W2967364098 cites W2142676369 @default.
• W2967364098 cites W2148558870 @default.
• W2967364098 cites W2155127143 @default.
• W2967364098 cites W2159205789 @default.
• W2967364098 cites W2163662732 @default.
• W2967364098 cites W2165352420 @default.
• W2967364098 cites W2335889607 @default.
• W2967364098 cites W2342852036 @default.
• W2967364098 cites W2607875207 @default.
• W2967364098 cites W2791571775 @default.
• W2967364098 cites W3082443879 @default.
• W2967364098 cites W315538801 @default.
• W2967364098 cites W4363260 @default.
• W2967364098 doi "https://doi.org/10.3390/cancers11081138" @default.
• W2967364098 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6721810" @default.
• W2967364098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31398954" @default.
• W2967364098 hasPublicationYear "2019" @default.
• W2967364098 type Work @default.
• W2967364098 sameAs 2967364098 @default.
• W2967364098 citedByCount "11" @default.
• W2967364098 countsByYear W29673640982020 @default.
• W2967364098 countsByYear W29673640982021 @default.
• W2967364098 countsByYear W29673640982022 @default.
• W2967364098 countsByYear W29673640982023 @default.
• W2967364098 crossrefType "journal-article" @default.
• W2967364098 hasAuthorship W2967364098A5045538077 @default.
• W2967364098 hasAuthorship W2967364098A5049975494 @default.
• W2967364098 hasAuthorship W2967364098A5053699829 @default.
• W2967364098 hasAuthorship W2967364098A5055536684 @default.
• W2967364098 hasAuthorship W2967364098A5057197316 @default.
• W2967364098 hasAuthorship W2967364098A5086946782 @default.
• W2967364098 hasAuthorship W2967364098A5089761965 @default.
• W2967364098 hasAuthorship W2967364098A5091811703 @default.
• W2967364098 hasBestOaLocation W29673640981 @default.
• W2967364098 hasConcept C150903083 @default.
• W2967364098 hasConcept C153911025 @default.
• W2967364098 hasConcept C159654299 @default.
• W2967364098 hasConcept C185592680 @default.
• W2967364098 hasConcept C190283241 @default.
• W2967364098 hasConcept C202751555 @default.
• W2967364098 hasConcept C203014093 @default.
• W2967364098 hasConcept C207001950 @default.
• W2967364098 hasConcept C2777325958 @default.
• W2967364098 hasConcept C2781164371 @default.
• W2967364098 hasConcept C502942594 @default.
• W2967364098 hasConcept C542903549 @default.
• W2967364098 hasConcept C54355233 @default.
• W2967364098 hasConcept C55493867 @default.
• W2967364098 hasConcept C81885089 @default.
• W2967364098 hasConcept C86803240 @default.
• W2967364098 hasConceptScore W2967364098C150903083 @default.
• W2967364098 hasConceptScore W2967364098C153911025 @default.
• W2967364098 hasConceptScore W2967364098C159654299 @default.
• W2967364098 hasConceptScore W2967364098C185592680 @default.
• W2967364098 hasConceptScore W2967364098C190283241 @default.
• W2967364098 hasConceptScore W2967364098C202751555 @default.
• W2967364098 hasConceptScore W2967364098C203014093 @default.
• W2967364098 hasConceptScore W2967364098C207001950 @default.

• next